Stay updated on Oncolytics Biotech Press Releases
Sign up to get notified when there's something new on the Oncolytics Biotech Press Releases page.

Latest updates to the Oncolytics Biotech Press Releases page
- Check3 days agoChange DetectedThe end-of-day stock quote display was updated (showing $1.16 with a 0.87% change), replacing the prior $1.07 with -2.64%.SummaryDifference0.9%

- Check10 days agoChange DetectedStock quote information updated: price is $1.10, daily change is $0.08, and the percentage is 7.84%. This replaces the previous values of $0.91, $0.006, and 0.67%.SummaryDifference0.9%

- Check17 days agoChange DetectedAdded new content sections to the Investor Overview, including pelareorep-focused information, a Press Releases area, and an Events section with links. Updated navigation to include Investor Overview, Press Releases, and Events, and removed older News search and year filters.SummaryDifference9%

- Check25 days agoChange DetectedAdded a press release about the domicile change to the United States (April 1, 2026). Deleted a press release expanding the Gastrointestinal Tumor Scientific Advisory Board with the addition of Dr. Eileen O’Reilly, Dr. Neil Segal, and Dr. Van Morris (January 7, 2026).SummaryDifference1%

- Check32 days agoChange DetectedAdded a March 19, 2026 press release about presenting new data at AACR 2026 and removed the December 16, 2025 press release on KRAS-Mutant metastatic colorectal cancer.SummaryDifference1%

- Check53 days agoChange DetectedThe page adds a new press release about a randomized colorectal cancer study and adds navigation to Our Mission, Board of Directors, and Resources. It removes the Media, Careers, Contact, and News sections.SummaryDifference6%

Stay in the know with updates to Oncolytics Biotech Press Releases
Enter your email address, and we'll notify you when there's something new on the Oncolytics Biotech Press Releases page.